BioCentury | Nov 17, 2014
Company News

NuView, Otsuka Pharmaceutical deal

...NuView granted Otsuka exclusive, worldwide rights to develop and commercialize NuView's genomic-based vasoactive intestinal peptide receptor...
...applications. Otsuka will provide funding for all future clinical trials and commercialization, and will use NuView's...
...Phase I trial "in the coming months." The partners could not be reached for details. NuView...
BioCentury | Mar 11, 2013
Clinical News

Cu-64-TP3805 diagnostic data

...Calif.) that has CE Mark approval in the EU and 510(k) clearance in the U.S. NuView Life Sciences Inc....
BioCentury | Jun 14, 2010
Company News

NuView, Thomas Jefferson University deal

...vasoactive intestinal peptide receptor 1 (VPAC1) on prostate cancer cells. Further details were not disclosed. NuView Life Sciences Inc....
BioCentury | Nov 9, 2009
Clinical News

NuView preclinical data

...over expressed in all breast cancers. Data were published in the Journal of Nuclear Medicine. NuView Life Sciences Inc....
BioCentury | Mar 10, 2008
Company News

NuView Radiopharmaceuticals Inc., University of Southern California deal

...in preclinical testing to image the heart and blood flow. Financial terms were not disclosed. NuView...
Items per page:
1 - 5 of 5
BioCentury | Nov 17, 2014
Company News

NuView, Otsuka Pharmaceutical deal

...NuView granted Otsuka exclusive, worldwide rights to develop and commercialize NuView's genomic-based vasoactive intestinal peptide receptor...
...applications. Otsuka will provide funding for all future clinical trials and commercialization, and will use NuView's...
...Phase I trial "in the coming months." The partners could not be reached for details. NuView...
BioCentury | Mar 11, 2013
Clinical News

Cu-64-TP3805 diagnostic data

...Calif.) that has CE Mark approval in the EU and 510(k) clearance in the U.S. NuView Life Sciences Inc....
BioCentury | Jun 14, 2010
Company News

NuView, Thomas Jefferson University deal

...vasoactive intestinal peptide receptor 1 (VPAC1) on prostate cancer cells. Further details were not disclosed. NuView Life Sciences Inc....
BioCentury | Nov 9, 2009
Clinical News

NuView preclinical data

...over expressed in all breast cancers. Data were published in the Journal of Nuclear Medicine. NuView Life Sciences Inc....
BioCentury | Mar 10, 2008
Company News

NuView Radiopharmaceuticals Inc., University of Southern California deal

...in preclinical testing to image the heart and blood flow. Financial terms were not disclosed. NuView...
Items per page:
1 - 5 of 5